- MNTA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.7 million.
- MNTA has traded 1.0 million shares today.
- MNTA is down 3.8% today.
- MNTA was up 6.7% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MNTA with the Ticky from Trade-Ideas. See the FREE profile for MNTA NOW at Trade-Ideas More details on MNTA: Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. Currently there are 5 analysts that rate Momenta Pharmaceuticals a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for Momenta Pharmaceuticals has been 1.1 million shares per day over the past 30 days. Momenta has a market cap of $1.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.86 and a short float of 16.7% with 9.11 days to cover. Shares are up 90% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.